Microdose Journal

Scientific News, Journal Papers, Studies for Microdosing for Mental Health

Menu
  • About MicrodoseJournal.com
  • Conferences
  • Contact
  • Find Psychedelic Therapy Providers:
  • News
  • Psychedelic Studies & Research Centers
  • Retreats
  • Scientific Papers
  • Video
Menu

Psilocin and Ketamine Microdosing: Effects of Subchronic Intermittent Microdoses in the Elevated Plus-Maze in Male Wistar Rats.

Posted on January 16, 2020January 16, 2020 by Research

Behavioural Pharmacology Sep 2018 29(6) 530-536

Horsley, Rachel R.; Palenicek, Tomas; Kolin, Jan; Vales, Karel

Abstract:
Short-term moderate doses of serotonergic and dissociative hallucinogens can be useful in the treatment of anxiety, Recently, a trend has developed for long-term intermittent ‘microdosing’ (usually one-tenth of a ‘full’ active dose), with reports of long-lasting relief from anxiety and related disorders; however, there is no scientific evidence for the efficacy of therapeutic microdosing nor to show its lasting effects. The objective of this study was to test for lasting effects on anxiety in rats after miicrodosing with ketamine or psilocybln, Over six days, Wistar rats (N=40) were admmistered ketamine (0.5 or 3 mg/kg), psilocin (0.05 or 0.075 mg/kg), or saline on three occasions. A five-minute elevated plus-maze test was conducted 48 hours after the final drug treatment (n=8). Dependent variables were entries (frequency), spent time (%), and distance traveled (cm) in each zone, as well as total frequency of rears, stretch-attend postures, and head clips. Statistical analyses of drug effects used separate independent one-way analysis of variance and pair-wise comparisons using independent t-tests. Statistical effects were modest or borderline and were most consistent with a mildly anxiogenic profile, which was significant at lower doses; however, this conclusion remains tentative. The lower doses of ketamine and psilocin produced comparable effects (to one another) across each variable, as did the higher doses. This pattern of effects may suggest a common (e.g. neurotransmitter/receptor) mechanism. We conclude that microdosing with hallucinogens for therapeutic purposes might be counterproductive; however, more research is needed to confirm our findings and to establish their translational relevance to clinical ‘psychedelic’ therapy.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About This Site

The Microdose Journal provides scientific studies and articles relating to the phenomenon of microdosing for the improvement of mental health.  It is also a resource for major study centers, conferences, and therapy centers that utilize psychedelics.

Recent Posts

  • A Review of LSD Treatment in Alcoholism
  • Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
  • The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
  • The ethics of psychedelic research in disorders of consciousness
  • Psychedelic Support
  • Santa Cruz, California City Council Approves Decriminalization Measure Measure for Psychedelics
  • Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers
  • Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions
  • Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being
  • The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving
© 2023 Microdose Journal | Powered by Minimalist Blog WordPress Theme